EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review

Fabiana C P S Lopes iD, Moise L Levy, Jennifer S Ruth, Ginna Priola, Shoshana Greenberger

Pediatric Dermatology · 2025

DOI: 10.1111/pde.70071 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pediatric Dermatology, 2025. Verfasst von Fabiana C P S Lopes und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine/Dermatology, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA. Hauptthemen laut MEDLINE: Sirolimus, Skin Neoplasms, Hemangioma, Antibiotics, Antineoplastic. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 30 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Infantile hemangiomas (IHs) are common, benign vascular tumors frequently managed with beta‐blockers as first‐line therapy. While most IHs respond to propranolol, a subset of severe, refractory, or life‐threatening lesions requires alternative interventions. Sirolimus (rapamycin), a mammalian target of rapamycin (mTOR) pathway inhibitor, has emerged as a promising second‐line treatment option for complicated IHs, particularly those with visceral involvement, airway compromise, functional impairment, or significant cosmetic consequences. This article reviews reported clinical experiences and mechanistic insights supporting the use of sirolimus in managing complex IHs and proposes a protocol to guide patient selection, dosing, and monitoring.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SirolimusSkin NeoplasmsHemangiomaAntibiotics, AntineoplasticMTOR InhibitorsHumansInfant

Stichwörter der Autor:innen

hemangiomamTOR inhibitorpediatricssirolimusvascular neoplasms

Substanzen

SirolimusAntibiotics, AntineoplasticMTOR Inhibitors

Autor:innen und Institutionen

  • Department of Medicine/Dermatology, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA.
  • Dell Children's Medical Group, Ascension Seton, Austin, Texas, USA.
  • Department of Pediatrics, Dell Medical School at the University of Texas at Austin, Austin, Texas, USA.
  • Pediatric Dermatology Unit, Department of Dermatology, Sheba Medical Center, Ramat Gan, Israel.
  • Gray Faculty of Medical & Health Sciences, Tel Aviv University, Tel Aviv-Yafo, Israel.

ORCID-Profile: Fabiana C P S Lopes

Zitieren

APA

Lopes, F. C. P. S., Levy, M. L., Ruth, J. S., Priola, G., & Greenberger, S. (2025). Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review. Pediatric Dermatology. https://doi.org/10.1111/pde.70071

Vancouver

Lopes FCPS, Levy ML, Ruth JS, Priola G, Greenberger S. Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review. Pediatric Dermatology. 2025. doi:10.1111/pde.70071

BibTeX
@article{Lopes2025,
  author = {Lopes, Fabiana C P S and Levy, Moise L and Ruth, Jennifer S and Priola, Ginna and Greenberger, Shoshana},
  title = {Sirolimus in the Management of Complex Infantile Hemangiomas: A State‐of‐the‐Art Review},
  journal = {Pediatric Dermatology},
  year = {2025},
  doi = {10.1111/pde.70071}
}
Kostenlos starten →